“…With the advent of the digital age, smart wearable devices and health management systems have received a lot of attention due to the ease with which they can be used to monitor individual health anywhere, anytime. − Currently, commercially available wearable sensors usually focus on physical metrics including body temperature, heart rate, human movement, and falls. As a non-invasive and easily accessible biofluid, sweat has been used to monitor human physiology and assess individual health status due to the presence of various biomarkers such as glucose, urea, amino acids, electrolytes, and levodopa ( l -dopa). − For example, the standard diagnosis used to detect cystic fibrosis is usually quantified by assessing the concentration of chloride, and glucose in sweat is used to monitor diabetes and hypoglycemia. − In the treatment of Parkinson’s disease (PD), dynamic monitoring of l -dopa in sweat can be used to assess the development of pharmacological management and non-motor complications . It is critical to note that sweat monitoring for biomarkers such as glucose and cortisol in situ is dependent on enzymes or antibodies. − However, it is a fact that has to be acknowledged that natural enzymes and antibodies are susceptible to degradation after exposure to harsh environments or contamination by body fluids, and, as a result, exhibit an associated loss of functionality that greatly affects the lifetime and accuracy of sweat sensors.…”